Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

Condition:   Overactive Bladder Syndrome Interventions:   Drug: Mirabegron;   Drug: Solifenacin Sponsor:   Far Eastern Memorial Hospital Not yet recruiting

Source: ClinicalTrials.gov - July 17, 2019 Category: Research Source Type: clinical trials